ENTITY

Myriad Genetics (MYGN US)

13
Analysis
Health CareUnited States
Myriad Genetics, Inc. develops and markets molecular diagnostic products to provide physicians with information to help guide the care of their patients, to prevent disease, delay the onset of disease, or catch disease at an early stage.
more
Company Event04 Jun 2026 22:00 • Upcoming
Add To Calendar
Company Event10 Jun 2026 20:40 • Upcoming
Add To Calendar
Company Event05 Aug 2026 04:30 • Upcoming
Add To Calendar
Company Event06 May 2026 04:30 • Latest
Company Event14 Apr 2026 20:00 • Upcoming
Add To Calendar
x